Drug and clinical candidate information for ednra (ChEMBL ID: CHEMBL252):

Molecule: SPARSENTAN
ChEMBL ID: CHEMBL539423
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2023

Molecule: NEBENTAN
ChEMBL ID: CHEMBL2107760
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ENRASENTAN
ChEMBL ID: CHEMBL431651
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ZIBOTENTAN
ChEMBL ID: CHEMBL1628688
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ATRASENTAN HYDROCHLORIDE
ChEMBL ID: CHEMBL2106068
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TEZOSENTAN
ChEMBL ID: CHEMBL61780
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AVOSENTAN
ChEMBL ID: CHEMBL3989834
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CLAZOSENTAN
ChEMBL ID: CHEMBL109648
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DARUSENTAN
ChEMBL ID: CHEMBL23261
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BQ-123
ChEMBL ID: CHEMBL1269102
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for ednra (ChEMBL ID: CHEMBL2096678):

Molecule: BOSENTAN
ChEMBL ID: CHEMBL957
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2001

Molecule: AMBRISENTAN
ChEMBL ID: CHEMBL1111
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2007

Molecule: MACITENTAN
ChEMBL ID: CHEMBL2103873
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2010

Molecule: SITAXENTAN
ChEMBL ID: CHEMBL282724
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: SITAXENTAN SODIUM
ChEMBL ID: CHEMBL2105740
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2006

Molecule: APROCITENTAN
ChEMBL ID: CHEMBL2165326
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule
